News|Articles|July 1, 2015
Biologics Development and Manufacturing Trends, Part 2
Eric Langer, Managing partner at BioPlan Associates, speaks with Pharmaceutical Technology about biosimilar development trends.
Advertisement
Eric Langer, Managing Partner at BioPlan Associates, spoke with Pharmaceutical Technology about biosimilar development trends.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
3
Challenges for the Global Manufacturing of Vaccines
4
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
5
